BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Castro R, Perazzo H, Grinsztejn B, Veloso VG, Hyde C. Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective. Int J Hepatol. 2015;2015:852968. [PMID: 26693356 DOI: 10.1155/2015/852968] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Schwambach KH, Farias MR, Neto GB, Blatt CR. Cost and Effectiveness of the Treatment of Chronic Hepatitis C in Brazil: Real-World Data. Value Health Reg Issues 2020;23:49-54. [PMID: 32702649 DOI: 10.1016/j.vhri.2020.05.002] [Reference Citation Analysis]
2 Perazzo H, Pacheco AG, Luz PM, Castro R, Hyde C, Fittipaldi J, Rigolon C, Cardoso SW, Grinsztejn B, Veloso VG. Age-standardized mortality rates related to viral hepatitis in Brazil. BMC Infect Dis 2017;17:527. [PMID: 28760138 DOI: 10.1186/s12879-017-2619-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
3 Schwambach KH, Blatt CR. Effectiveness and potential drug interactions in antiviral therapy for the treatment of chronic hepatitis C: real-life data from a specialized center in southern Brazil. Braz J Pharm Sci 2021;57:e18746. [DOI: 10.1590/s2175-9790201900041874] [Reference Citation Analysis]
4 Borba HHL, Rochau U, Wiens A, Sroczynski G, Siebert U, Ferreira VL, Minowa E, Pontarolo R. Effectiveness and Cost-Effectiveness of Triple Therapy With Telaprevir and Boceprevir for Chronic Hepatitis C: A Decision Analysis From the Brazilian Public Health System Perspective. Value Health Reg Issues 2019;20:95-102. [PMID: 31108456 DOI: 10.1016/j.vhri.2019.02.005] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Pessoa MG, Ramalho-Madruga JV, Alves K, Nunes EP, Cheinquer H, Brandão-Mello CE, Mendes-Correa MC, Ferraz ML, Ferreira PRA, Álvares-da-Silva MR, Coelho HS, Affonso-de-Araújo ES, Furtado J, Parana R, Silva G, Lari SA, Liu L, Tripathi R, Pilot-Matias T, Cohen DE, Shulman NS, Martinelli A. Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir ± Ribavirin for HCV in Brazilian Adults with Advanced Fibrosis. Ann Hepatol 2018;17:959-68. [PMID: 30600291 DOI: 10.5604/01.3001.0012.7196] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Paranaguá-Vezozzo DC, Andrade A, Mazo DFC, Nunes V, Guedes AL, Ragazzo TG, Moutinho R, Nacif LS, Ono SK, Alves VAF, Carrilho FJ. Concordance of non-invasive mechanical and serum tests for liver fibrosis evaluation in chronic hepatitis C. World J Hepatol 2017; 9(8): 436-442 [PMID: 28357031 DOI: 10.4254/wjh.v9.i8.436] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]